TearClear Appoints Dr. Amir Shojaei Chief Development Officer
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, a global ophthalmic pharmaceutical company, has announced the appointment of... Read More
UF Startup TearClear Appoints Robert J. Dempsey as CEO
UF startup TearClear, a global Ophthalmic Pharmaceutical Company, announced the appointment of Robert J. Dempsey as Chief Executive Officer. TearClear, a resident... Read More
